UMass Boston

The CPCT research team, which includes faculty, postdoctoral fellows, graduate students, and undergraduate students, works towards understanding molecular and cellular mechanisms promoting cancer initiation and progression, and using this information to develop disease biomarkers and anti-cancer therapeutics.

About Us

The mission of the center is to:

• Build capacity and research infrastructure for use by students and faculty as well as small/startup biotechs.
• Function as an academic/industry hybrid to develop oncology-related therapeutics and biomarkers with significant clinical utility.
• Contribute to workforce development in the Commonwealth to increase the competitiveness of University of Massachusetts Boston students so they will become the future leaders of life sciences research in academia and industry. 

The CPCT seeks to understand the molecular and cellular mechanisms that promote cancer initiation and progression, and use this information to develop disease biomarkers and anti-cancer therapeutics.

The Center for Personalized Cancer Therapy (CPCT) is a joint program of the University of Massachusetts Boston and the Dana Farber/Harvard Cancer Center (DF/HCC).